EUVIMEDEUVIMED entdecken
Crossref

Rare bleeding disorders: Advances in management

Alessandro Casini iD, Hanny Al-Samkari iD, Catherine Hayward iD, Flora Peyvandi iD

Haemophilia · 2024

DOI: 10.1111/hae.14986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haemophilia, 2024. Verfasst von Alessandro Casini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology and Hemostasis, University Hospitals of Geneva and Faculty of Medicine of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Blood Coagulation Disorders, Afibrinogenemia, Antifibrinolytic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited factor coagulation deficiencies and vascular bleeding disorders, associated with bleeding of various severity, are often classified as rare bleeding disorders (RBDs). These include inherited fibrinogen disorders, inherited platelet function disorders (IPFD) and hereditary haemorrhagic telangiectasia (HHT). In the last decades, there have been large increases in knowledge on the epidemiology, genetics, physiopathology, clinical features, and diagnosis of RBDs, but improvements in management have been more limited and remain challenging. The treatment mainstay of RBDs is based only on replacement of a few available coagulation factor concentrates or cryoprecipitates. There is growing interest in therapeutic agents that enhance coagulation or inhibiting anticoagulant pathways in RBDs. In severe IPFD, the optimal platelet transfusion strategy is not yet established. Moreover, data is scarce on the effectiveness and safety of desmopressin and/or antifibrinolytic drugs often used for milder IPFD treatment. The best fibrinogen replacement strategy (prophylaxis vs. on demand) in afibrinogenemia is still debated. Similarly, the optimal trough fibrinogen target level for treatment of acute bleeding, and the role of fibrinogen replacement during pregnancy in mild hypofibrinogenemia and dysfibrinogenemia, have not been properly evaluated. The therapeutic arsenal in HHT includes antifibrinolytics and a series of antiangiogenic agents whose potential efficacy has been tested in small studies or are under investigation for treatment of bleeding. However, there is need to address several issues, including the optimal dosing strategies, the potential emergent toxicity of longer‐term use, and the impact of systemic antiangiogenic treatment on visceral arteriovenous malformations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Coagulation DisordersAfibrinogenemiaAntifibrinolytic AgentsPregnancyFemaleHumansHemorrhageFibrinogenBlood Coagulation Factors

Stichwörter der Autor:innen

fibrinogen deficiencyhereditary haemorrhagic telangiectasiainherited platelet dysfunctionrare bleeding disorders

Substanzen

FibrinogenBlood Coagulation FactorsAntifibrinolytic Agents

Autor:innen und Institutionen

  • Division of Angiology and Hemostasis, University Hospitals of Geneva and Faculty of Medicine of Geneva, Geneva, Switzerland.
  • Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Departments of Pathology and Molecular Medicine, and Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

ORCID-Profile: Alessandro Casini, Hanny Al-Samkari, Catherine Hayward, Flora Peyvandi

Zitieren

APA

Casini, A., Al-Samkari, H., Hayward, C., & Peyvandi, F. (2024). Rare bleeding disorders: Advances in management. Haemophilia. https://doi.org/10.1111/hae.14986

Vancouver

Casini A, Al-Samkari H, Hayward C, Peyvandi F. Rare bleeding disorders: Advances in management. Haemophilia. 2024. doi:10.1111/hae.14986

BibTeX
@article{Casini2024,
  author = {Casini, Alessandro and Al-Samkari, Hanny and Hayward, Catherine and Peyvandi, Flora},
  title = {Rare bleeding disorders: Advances in management},
  journal = {Haemophilia},
  year = {2024},
  doi = {10.1111/hae.14986}
}
Kostenlos starten →